SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 213 filers reported holding SEATTLE GENETICS INC in Q1 2014. The put-call ratio across all filers is 2.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $575,279,000 | +14.9% | 2,939,746 | -0.3% | 0.04% | +8.3% |
| Q2 2020 | $500,891,000 | +34.4% | 2,947,802 | -8.7% | 0.04% | +9.1% |
| Q1 2020 | $372,645,000 | +4.8% | 3,229,723 | +3.8% | 0.03% | +37.5% |
| Q4 2019 | $355,573,000 | +26.5% | 3,111,963 | -5.5% | 0.02% | +14.3% |
| Q3 2019 | $281,154,000 | +28.2% | 3,292,202 | +3.9% | 0.02% | +31.2% |
| Q2 2019 | $219,311,000 | -8.1% | 3,168,778 | -2.8% | 0.02% | -15.8% |
| Q1 2019 | $238,769,000 | +43.8% | 3,260,085 | +11.2% | 0.02% | +26.7% |
| Q4 2018 | $166,077,000 | -24.8% | 2,931,114 | +2.3% | 0.02% | -11.8% |
| Q3 2018 | $220,973,000 | +15.7% | 2,865,234 | -0.4% | 0.02% | +6.2% |
| Q2 2018 | $191,056,000 | +16.2% | 2,877,791 | -8.4% | 0.02% | +14.3% |
| Q1 2018 | $164,392,000 | +8.3% | 3,140,904 | +10.7% | 0.01% | +16.7% |
| Q4 2017 | $151,794,000 | -13.7% | 2,837,281 | -12.2% | 0.01% | -20.0% |
| Q3 2017 | $175,842,000 | +21.0% | 3,231,747 | +15.0% | 0.02% | +15.4% |
| Q2 2017 | $145,377,000 | -18.7% | 2,809,762 | -1.2% | 0.01% | -18.8% |
| Q1 2017 | $178,847,000 | +32.1% | 2,845,120 | +10.9% | 0.02% | +23.1% |
| Q4 2016 | $135,404,000 | +26.4% | 2,566,041 | +29.4% | 0.01% | +18.2% |
| Q3 2016 | $107,109,000 | +31.7% | 1,983,063 | -1.5% | 0.01% | +22.2% |
| Q2 2016 | $81,321,000 | -0.1% | 2,012,517 | -13.2% | 0.01% | 0.0% |
| Q1 2016 | $81,406,000 | -7.5% | 2,319,710 | +18.3% | 0.01% | -10.0% |
| Q4 2015 | $88,018,000 | +35.7% | 1,961,413 | +16.6% | 0.01% | +25.0% |
| Q3 2015 | $64,850,000 | -17.1% | 1,681,774 | +4.1% | 0.01% | 0.0% |
| Q2 2015 | $78,214,000 | +28.1% | 1,616,012 | -6.4% | 0.01% | +33.3% |
| Q1 2015 | $61,063,000 | +12.7% | 1,727,394 | +2.4% | 0.01% | +20.0% |
| Q4 2014 | $54,204,000 | -7.9% | 1,687,104 | +6.5% | 0.01% | -16.7% |
| Q3 2014 | $58,884,000 | -1.5% | 1,583,890 | +1.4% | 0.01% | 0.0% |
| Q2 2014 | $59,777,000 | -15.0% | 1,562,703 | +1.3% | 0.01% | -25.0% |
| Q1 2014 | $70,290,000 | -43.9% | 1,542,679 | -63.9% | 0.01% | 0.0% |
| Q4 2013 | $125,354,000 | +75.2% | 4,278,076 | +162.1% | 0.01% | -11.1% |
| Q3 2013 | $71,546,000 | +28.7% | 1,632,391 | -7.6% | 0.01% | +28.6% |
| Q2 2013 | $55,610,000 | – | 1,767,585 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |